Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis
Under a Creative Commons license
open access
Abbreviations
ACEI
Angiotensin-converting enzyme inhibitor
ARB
Angiotensin receptor blocker
CI
Confidence interval
eGFR
Estimated glomerular filtration rate
ERT
Enzyme replacement therapy
FOS
Fabry Outcome Survey
LVH
Left ventricular hypertrophy
LVMI
Left ventricular mass indexed to height
MDRD
Modification of Diet in Renal Disease
SE
Standard error
SEM
Standard error of the mean
Keywords
Fabry disease
Enzyme replacement therapy
Agalsidase alfa
Long-term effectiveness
Cited by (0)
Copyright © 2015 The Authors. Published by Elsevier Inc.